Advertisement

Topics

Latest "LithoLink Corporation" News Stories - Page: 5

01:32 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "LithoLink Corporation" found in our extensive news archives from over 250 global news sources.

More Information about LithoLink Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about LithoLink Corporation for you to read. Along with our medical data and news we also list LithoLink Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of LithoLink Corporation Companies for you to search.

Showing "LithoLink Corporation" News Articles 101–125 of 521

Probably Relevant

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

 ORION CORPORATION                                            PRESS RELEASE                      10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation Johanna Ivaska (born 1972), Academy Professor of Biochemistry has been appointed Head & Vice ...


Global Cloud Security in Healthcare Market Segmented by Application, Deployment, Component, EndUser and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global cloud security in the healthcare market is expected to register a CAGR of approximately 18.2% during the forecast period, 2018 to 2023. North America dominates the market due to the favorable regulatory framework by the government and technological developments in that region.Cloud computing is one of the major shift from the traditional way of doing business to use the IT resources. Cl...

Zealand hosts conference call on November 15 at 4 pm CET (10 am EST) to present third quarter results for 2018

Press Release - No. 22 / 2018   Zealand hosts conference call on November 15 at 4 pm CET (10 am EST) to present third quarter results for 2018 Copenhagen, November 8, 2018 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference call on November 15, 2018 at 4 pm CET/10 am EST following the announcement of its Q3 2018 resu...


Active Biotech AB - Interim report January - September 2018

                                  Third quarter in brief Active Biotech provides update on laquinimod in Huntington's disease Active Biotech regains global rights to the development and commercialization of laquinimod Data from the LEGATO-HD study of laquinimod in Huntington's disease presented at the EHDN meeting Events after t...

DBV Technologies to Present at the Cantor Global Healthcare Conference

Montrouge, France, September 25, 2018 DBV Technologies to Present at the Cantor Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Susanna Mesa, Chief Business Officer, will present at the Cantor Global Healthcare Conference on Tuesday, October ...

Altasciences Completes Bioanalytical Laboratory Expansion

LAVAL, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Altasciences is excited to announce the completion of their laboratory expansion. The additional space will be dedicated to ligand binding and cell-based assays. Altasciences' bioanalytical services continue to grow, and the added, state-of-the-art lab area ensures capacity to continue delivering quality bioanalysis solutions to both thei...

Aino Health AB (publ): Aino Health appoints Tanja Ilic as COO

    September 27, 2018 Tanja Ilic has been appointed as COO, Chief Operating Officer, of Aino Health AB. The recruitment of Tanja strengthens Aino Health's ongoing expansion in both the Nordic region and internationally. Tanja will take up her position during the fall, at the latest on December 3. Aino Health, which provides SaaS solutions for Corporate Health Managemen...

Europe Food Sweetener Market Segmented by Product Type, Application and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3850

The Europe food sweetener market records a revenue of USD 11055.02 million in 2016 and is expected to grow at a CAGR of 1.7 % during the forecast period of 2018 2023. Europe accounts for the thirdlargest market for bulk sweetener market. The high consumption and production of bakery and confectionery products in Europe have increased its applications.Growing Consumer Trends towards Natural Ingred...

Europe Food Sweetener Market Segmented by Product Type, Application and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1922

The Europe food sweetener market records a revenue of USD 11055.02 million in 2016 and is expected to grow at a CAGR of 1.7 % during the forecast period of 2018 2023. Europe accounts for the thirdlargest market for bulk sweetener market. The high consumption and production of bakery and confectionery products in Europe have increased its applications.Growing Consumer Trends towards Natural Ingred...

Global Vendor Neutral Archive VNA PACS Market Segmented by Application, Delivery Mode, Usage Model, Player type and Geography Growth, Trend and Forecast 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global Vendor Neutral Archive VNA PACS market has been estimated at USD 3.28 billion in 2017. The market is expected to register a CAGR of 5.9% during the forecast period, 2018 to 2023. North America accounted for the largest market share, accounting for approximately 60% of the global market share in 2017, while Europe region was estimated to register the fastest CAGR through the forecast pe...

Aino Health AB (publ): Aino Health's solution go-live for the municipality of Botkyrka

    September 26 2018 Aino Health go-live with its SaaS solution to decrease sick leave within the municipality of Botkyrka and is at the same time introducing the concept of social impact bonds in Sweden. The remuneration model means that Aino Health is investing in services and consultancy, which are directly connected to improved social results for Botkyrka. The goal is to de...

Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer

Press release Malmö, November 13, 2018 Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer. Per Persson comes directly from the role as Chief Commercial Officer of Acarix. Christian Lindholm, who has served as interim CEO since February 2018, resumes his role as Chief Financial Officer. The changes are effective immediat...

LIDDS receives approval from MPA to start Phase I study NZ-DTX-001

The Swedish Medical Product Agency has approved a first-in-human study, NZ-DTX-001, in which solid tumors will be treated with NanoZolid combined with docetaxel. This is LIDDS' second clinical project and will initially include patients at Karolinska University Hospital in Sweden. The Phase I study will assess the safety and tolerability of intratumoral treatment of patients with advan...

Stryker announces organizational changes

Kalamazoo, Michigan - July 10, 2018 - Stryker Corporation (NYSE:SYK) announced today that David K. Floyd, Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the CEO and will assist with transitioning his responsibilities to our newly appointed leaders while also...

Changes in responsibility areas of the Orion Group Executive Management Board

ORION CORPORATION       STOCK EXCHANGE RELEASE      19 SEPTEMBER 2018 at 11.45 a.m. EEST                      Changes in responsibility areas of the Orion Group Executive Management Board The following changes have been decided in responsibility areas of the Orion Group Executive Management Board: As of 1 October, 2018: Mr. Markku Huhta-Koivisto,...

Global Immunoassays Market Segmented by Technology, Therapeutics Area and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global Immunoassay market has been estimated to reach 17.16 billion in 2017. : The global Immunoassays market is expected to register a CAGR of 9.7% during the forecast period, 2018 to 2023. North America dominates the market due to the technological advancement in the immunoassay products and rising incidence in the chronic diseases like thyroid, cardiovascular diseases.High Sensitivity and S...

Global Immunoassays Market Segmented by Technology, Therapeutics Area and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global Immunoassay market has been estimated to reach 17.16 billion in 2017. : The global Immunoassays market is expected to register a CAGR of 9.7% during the forecast period, 2018 to 2023. North America dominates the market due to the technological advancement in the immunoassay products and rising incidence in the chronic diseases like thyroid, cardiovascular diseases.High Sensitivity and S...

North America Oilfield Chemicals Market Segmented by Chemical Type, Application, and Geography Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3850

The North American oilfield chemicals market is estimated to value at USD 15,474.00 million in 2017 and projecting a CAGR of 4.89%, during the forecast period 20182023. The market is driven by several factors, such as growing demand for oilfield chemicals due to increasing crude oil production, and shifting focus towards the development of ecofriendly chemicals.Demand for Oilfield Chemicals Bolste...

Global Smart Healthcare Products Market Segmented by Product Type, Applications and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The global smart healthcare products market is expected to register a CAGR of about 12.5% during 20182023 the forecast period. North America dominates the market due to the growing demand for integrated inventory management solutions, such as Smart RFID cabinets, and rising healthcare expenditure in the region.Growth in the Aging PopulationAging Population has been augmenting the demand for health...

Global Smart Healthcare Products Market Segmented by Product Type, Applications and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global smart healthcare products market is expected to register a CAGR of about 12.5% during 20182023 the forecast period. North America dominates the market due to the growing demand for integrated inventory management solutions, such as Smart RFID cabinets, and rising healthcare expenditure in the region.Growth in the Aging PopulationAging Population has been augmenting the demand for health...

Global and Asia Polyvinyl Alcohol Films Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Nexstim Plc to host a Conference Call / Webcast to Present New Depression Led Corporate Strategy

Press release, Helsinki, 25 th September 2018 at 9:00 AM EEST Nexstim Plc to host a Conference Call / Webcastto Present New Depression Led Corporate Strategy Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or the "Company"), the targeted neuromodulation company developing and marketing navigated personalised, non-invasive brain stimulation systems for the treat...

FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome

Myelo Therapeutics GmbH / FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. BERLIN, GERMANY, September 25, 2018 - Myelo Therapeutics GmbH announced today that the US Food and Drug Administration (FDA) has gr...

SPINEWAY :Spineway sets up the governing structure for its US subsidiary

Press release                                                                                                                                                                 Ecully, 15 November 2018 Spineway sets up the gove...

Xbrane Biopharma releases interim report for the third quarter of 2018

Press release2018-11-16   Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the third quarter of 2018 is now available on the Company's website, www.xbrane.com. Financial summary third quarter 2018 Revenue amounted to SEK 2,441 thousand (-). Gross margin amounted to 21% (-). Other operating income amounted to SEK 84,041 thousand (331), of w


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks